Genetic ancestry was not tied to worse MS disability

Genetic ancestry was not tied to worse MS disability
Credibility
Interest
Share:1 min read
Key Takeaway

In this UK study, African and South Asian genetic ancestry were not consistently linked to worse MS disability than European ancestry.

What They Found

Researchers compared MS disability across people with different genetic ancestries. African ancestry was not consistently linked to worse disability than European ancestry. The same was true for South Asian ancestry. The researchers also looked for inherited gene differences linked to MS disability. They found no gene differences with a strong enough link to meet their study's threshold.

Who Should Care and Why

This study included adults with MS living in the United Kingdom. It compared people with African, South Asian, European, and other genetic ancestries. The findings speak to whether ancestry helps explain differences in MS disability. African and South Asian ancestry were not consistently linked to greater disability than European ancestry. The researchers said their findings argue against a genetic explanation for previously observed differences in MS outcomes between ethnic groups.

Important Considerations

You should know this study included 816 people and measured their health at one point in time. Participants reported their own MS characteristics, including disability and age at diagnosis. The findings do not show whether ancestry affects how your MS changes over time.

AI-generated summary — for informational purposes only, not medical advice

You May Also Like

MS and a Common Virus: What New Blood Tests Reveal
MS and a Common Virus: What New Blood Tests Reveal

1/1/2027

A Korean study found higher levels of one Epstein-Barr virus antibody in people with MS. Learn why t

Read More
MS Research: What Spinal Fluid Immune Cells May Reveal
MS Research: What Spinal Fluid Immune Cells May Reveal

1/1/2027

Explore a study linking a gene change to immune cells in spinal fluid in MS, what those cells may sa

Read More
New Immune Treatment for Stiffness: What MS Can Learn
New Immune Treatment for Stiffness: What MS Can Learn

11/9/2026

A small study found a new immune treatment eased walking and stiffness in stiff person syndrome. Lea

Read More
MS Hospital Stays: Why Mental Health Checks Matter
MS Hospital Stays: Why Mental Health Checks Matter

11/9/2026

A U.S. study found anxiety, depression, and pain more often in MS hospital stays. Learn why asking f

Read More
MS and Anxiety: A Better Way to Spot Worry About the Future
MS and Anxiety: A Better Way to Spot Worry About the Future

11/8/2026

A study finds a short survey may help spot worry about the unknown in people with MS. Learn what it

Read More
Could Clearer Spine Scan Labels Help Track MS Changes?
Could Clearer Spine Scan Labels Help Track MS Changes?

11/7/2026

A new tool labels spine bones and discs on many scans. Learn how this could help doctors review MS-r

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.